Mangrove Partners’s Privia Health PRVA Stock Holding History

Mangrove Partners’s Portfolio PRVA Stock Details PRVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-27,153	Closed	-$559K	–	553
2026 Q1	$559K	Buy	+27,153	New	+$612K	0.05%	174

Other funds holding PRVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Mangrove Partners's PRVA Position: Q2 2026 in Review

Mangrove Partners sold out of Privia Health (PRVA) in Q2 2026, closing a stake of 27,153 shares — an estimated $559K sold.

Mangrove Partners first reported a position in PRVA in Q1 2026 and held it in 1 quarter. The position peaked at $559K in Q1 2026. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

Mangrove Partners reported no remaining Privia Health position as of Q2 2026 after selling out during the quarter.
Mangrove Partners sold 27,153 Privia Health shares in Q2 2026, an estimated $559K.
Mangrove Partners first reported a position in Privia Health in Q1 2026 and held it in 1 quarter.
Mangrove Partners's Privia Health position peaked at $559K in Q1 2026.
301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Mangrove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.